Correspondence 0001193125-22-309504 from HTG MOLECULAR DIAGNOSTICS, INC (HTGMQ) (CIK 0001169987)
HTG MOLECULAR DIAGNOSTICS, INC (HTGMQ) (CIK 0001169987)
Date: Dec. 21, 2022 · CIK: 0001169987 · Accession: 0001193125-22-309504
AI Filing Summary & Sentiment
File numbers found in text: 333-268681
Letter
HTG Molecular Diagnostics, Inc.
3430 E. Global Loop
Tucson, AZ
December 21, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Benjamin Richie and Abby Adams
Re: HTG Molecular Diagnostics, Inc.
Registration Statement on Form S-1, as amended (File No. 333-268681)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, HTG Molecular Diagnostics, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (as amended, the “Registration Statement”) and declare the Registration Statement effective as of 1:00 p.m., Eastern Time, on December 21, 2022, or as soon thereafter as possible, or at such other time as the Company or its counsel may request by telephone to the staff of the Commission. This request for acceleration is subject, however, to your receiving a telephone call prior to such time from Cooley LLP confirming this request. The Company hereby authorizes each of Steven M. Przesmicki and Asa M. Henin of Cooley LLP, counsel to the Company, to make such a request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Asa M. Henin of Cooley LLP at (858) 550-6104, or in his absence, Steven M. Przesmicki of Cooley LLP at (858) 550-6070.
Very truly yours,
HTG Molecular Diagnostics, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP HTG Molecular Diagnostics, Inc. 3430 E. Global Loop Tucson, AZ 85706 December 21, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Benjamin Richie and Abby Adams Re: HTG Molecular Diagnostics, Inc. Registration Statement on Form S-1, as amended (File No. 333-268681) Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, HTG Molecular Diagnostics, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (as amended, the “Registration Statement”) and declare the Registration Statement effective as of 1:00 p.m., Eastern Time, on December 21, 2022, or as soon thereafter as possible, or at such other time as the Company or its counsel may request by telephone to the staff of the Commission. This request for acceleration is subject, however, to your receiving a telephone call prior to such time from Cooley LLP confirming this request. The Company hereby authorizes each of Steven M. Przesmicki and Asa M. Henin of Cooley LLP, counsel to the Company, to make such a request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Asa M. Henin of Cooley LLP at (858) 550-6104, or in his absence, Steven M. Przesmicki of Cooley LLP at (858) 550-6070. Very truly yours, HTG Molecular Diagnostics, Inc. /s/ Shaun D. McMeans By: Shaun D. McMeans Title: SVP and Chief Financial Officer